Articles by Lonza Pharma & Biotech
  
Thursday, August 26, 2021 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST
This webcast will explore the benchmark practices for rapid progression from first-in-human to large-scale commercial manufacture for microdosing API. Micro-dosing at a commercial scale made effortless.

***Live: Thursday, January 28, 2021 at 11am EST | 8am PST | 4pm GMT | 5pm CET*** Amorphous solid dispersions (ASDs) are a critical technology for bioavailability enhancement. In this webcast Lonza’s Deanna Mudie and Aaron Stewart discuss Lonza’s best practices for ASD formulation development and in vitro testing.*** On demand available after final airing until Jan. 28, 2022.***

2020 Bio/Pharma Virtual Congress
ByINTERPHEX,Adare Pharma Solutions,Aizon,BASF,Beckman Coulter,Catalent,DocuSign,Honeywell,LIGHTHOUSE,Lonza Pharma & Biotech,LSNE,Mikart,Nelson Labs,Qualicaps,Shimadzu,suez,Thermo Fisher Scientific,VAI *** Live: Wednesday, November 11, 2020 | 8:30 AM EDT – 4:00 PM EDT *** 2020 Bio/Pharma Virtual Congress: Join Pharmaceutical Technology® and BioPharm International® for this online event that will explore the latest developments in formulation, manufacturing, and innovative drug dosage forms, as well as detailed discussions about crucial topics impacting the industry. ***On demand available after final airing until 11/11/2021

Learn more about speed-to-market, a critical aspect of developing new pharmaceutical products, and the significant interest on the science of scale for spray drying.

***Live: Friday, November 20, 2020 at 11am EST| 8am PST| 4pm GMT| 5pm CET*** Lipid multiarticulate (LMPs) are versatile drug delivery systems which offer flexibility in both drug release and final dosage form. This webinar discusses the process for formulation selection and LMP manufacturing through the lens of visual techniques.*** On demand available after final airing until Nov. 20, 2021.***

Executive summary presents clinical services and integrated first-in-human solutions for effective accelerated timelines support. Case studies demonstrates best practices in complex packaging and DtP supply.

In this webcast, Michael Grass PhD (Head of Solid Form Services, Global R&D) will present how solid form screening is performed and the importance of this work to drug substance and drug product development.
Live: Thursday, Sep. 10, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
On demand available after airing until Sep 10, 2021
Register free

This webcast focuses on manufacturing aspects of amorphous spray-dried dispersions to enable successful scale-up and optimization of the process. An overview of spray drying and typical scale-up challenges will be presented along with a robust process development strategy to ensure critical-to-quality attributes are maintained. Tools and methodologies that enable rapid scale-up that is right the first time from clinical to commercial scale will also be highlighted. 
Live: Tuesday, Aug. 4, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
On demand available after airing until Aug. 4, 2021
Register free

If you have a new compound for respiratory drug delivery, what particle engineering approach should you take? This webinar will explore both micronization and spray drying approaches in relation to product performance of the inhaled drug product.
Live: Thursday, Jul. 30, 2020 at 11am EDT | 8am PDT | 4pm GMT | 5pm CEST
On demand available after airing until Jul. 30, 2021
Register free

This webinar will review Lonza’s integrated clinical supply services inclusive of manufacturing, primary and secondary packaging, kitting, and distribution with special emphasis on complex clinical studies and direct-to-patient shipping.
Live: Tuesday, Jun. 23, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
On demand available after airing until Jun. 23, 2021
Register free

This webcast will cover physicochemical requirements and biological oral delivery barriers for peptides. Learn innovative approaches to derisk pharmaceutical development and increase the success rate of the first in human trials. 
Live: Wednesday, Apr. 1, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
On demand available after airing until Apr. 1, 2021
Register free

At Lonza Pharma & Biotech, we provide contract development and manufacturing services that enable biotech and pharma companies to bring large and small-molecule medicines to patients in need.

Join us for an informative webcast on March 12th at 11am EDT as we discuss the full capabilities of the Lonza Capsugel® Products and Services Portfolio. Our offerings include high-quality capsules, both in gelatin and specialty polymers, a premier portfolio of equipment, unparalleled industry and regulatory knowledge, and more. 
Live: Thursday, Mar. 12, 2020 at 11am EDT | 8am PDT | 3pm GMT | 4pm CET
On demand available after airing until Mar. 12, 2021
Register free

Oral administration of small molecules has become increasingly difficult due to a majority of new candidates demonstrating poor aqueous solubility. Dr. David Lyon will discuss a proven model-based technology selection methodology for poorly soluble molecules and an integrated formulation approach to minimize first-in-human timelines. 
Live: Wednesday, Oct. 23, 2019 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
On demand available after airing until Oct. 23, 2020
Register free

Drug development based on potent compounds can be quite challenging. Crossing the boundary from small molecule to biologics into antibody-drug conjugate (ADC) territory adds levels of complexity. Learn more about infrastructure requirements and best practices.
Live: Friday, Sept. 27, 2019 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
On demand available after airing until Sept. 27, 2020 
Register free

The objective of the webcast is to give an overview of the different size reduction techniques for tailoring particle size distribution. In particular, the speakers will focus on milling and micronization technologies and equipment selection. 
Live: Wednesday, Aug. 7, 2019 at 10am EDT | 9am CDT | 3pm BST | 4pm CEST
On demand available after airing until Aug. 7, 2020
Register free

Due to the intrinsic enteric properties of Capsugel® Vcaps® Enteric, no coating step is needed. It means that this capsule is a ready-to-use solution that can help you in obtaining significant cost and time savings during pharmaceutical development or compounding.